Cover picture © ALIMA

The Context

From 2014 to 2016, West Africa experienced the largest outbreak of Ebola ever recorded, which claimed more than 11,000 lives.

Ebola crossed borders and became a global crisis, from the outbreak’s epicenter in West Africa (Guinea, Liberia, Sierra Leone), with isolated cases spreading to neighboring countries (Mali, Senegal, Nigeria) as well as to Europe (Great Britain, Italy, Spain) and to the United States.

In 2014, faced with the scale of the crisis, ALIMA’s teams encountered numerous constraints in the Ebola treatment centers (ETCs). They made several observations:

  • The centers were expensive and took a long time to deploy.
  • Patient treatment required a large amount of qualified and experienced health workers and medical resources.
  • Health center operations were not conducive to effective case monitoring.
  • Sick patients were separated from their family and their community and were often reticent to seek treatment.

9 things to know about Ebola

ALIMA’s Response

In 2014 ALIMA intervened to respond to the Ebola epidemic in Guinea by:

  • building an Ebola treatment center;
  • providing quality medical assistance;
  • training Guinean medical personnel;
  • developing research projects on new treatment protocols (medicine) and in participating in clinical vaccine trials.

The following year, ALIMA received first prize of the European Union Health Award for making a “notable difference in fighting Ebola.”

© Yvonne Etinosa / ALIMA

Introducing the CUBE

Drawing from lessons learned in the aftermath of the epidemic, ALIMA and its partner Securotec developed the CUBE, the Biosecure Emergency Care Unit for Outbreaks. The CUBE is a self-contained and easily transportable system for outbreaks of highly-infectious disease.

The CUBE’s main advantage is that the health workers no longer need personal protective equipment (PPE) – the protection is centered on the patient. With its transparent walls and external arm entries, medical teams, with minimal training, can comfortably ensure a continuous monitoring of an infected patient, checking vitals, administering solutes and adapting treatment from the exterior, all while reducing the risk of contamination. The patient also benefits from the transparent walls which allow them to remain in contact with the outside, including family members, without the risk of contamination.

© Alexis Huguet / ALIMA

Technical Specifications

  • Small: 9m2 surface per unit
  • Easily transportable: 290 kg per unit
  • Fast: Can be deployed within 72 hours from the initial alert of outbreak, and set up in 90 minutes.
  • Reusable: up to 10 times
  • Inexpensive: Reduces the cost of intervention by 75%
  • Modular: Individual units can be combined
  • Adaptable: Can be adapted to any context, and assembled indoors or outdoors
  • Individualized medical care
  • Secure: Health workers benefit from biosafety level 4 protection
  • Nearly 80% of medical acts can be performed from the exterior, in a “Low Risk” setting
  • Transparent: The transparent walls allows for continuous patient monitoring, communication between health worker and patient, contact with family members
  • Comfort: Includes air conditioning and air filtration.


  • Laboratory: The CUBE can be used as a P4 level laboratory for diagnostics and research
  • Surgery: Can be used for surgical acts

Download the brochure (PDF) 

Dr. Richard Kojan, President of ALIMA, received the Reach Award “Game Changing Innovator”.

For more information

Contact us at :

Senegal office

Route des Almadies, Lot n° 22 zone 9
BP 15530, Dakar, Sénégal

France office

15, rue des immeubles industriels 75011 Paris
+33 (0)1 40 33 95 19

USA office

One Whitehall Street, 2nd Fl,
 New York NY 10004
+1 (646) 619-9074

Australia office

15 Hazlewood Street
New Farm, Brisbane
Queensland Australia 4005
 +61 419 744 274
Senegal office
Route des Almadies, Lot n° 22 zone 9
   BP 15530, Dakar, Sénégal
France office
15, rue des immeubles industriels
   75011 Paris France.
+33 (0)1 40 33 95 19
USA office
One Whitehall Street, 2nd Fl,
    New York NY 10004, USA
+1 (646) 619-9074
Australia office
PO Box 3716,
  Marsfield NSW 2122, Australia
+61 298682400
For the United States: 100% of your donation will be tax-deductible. ALIMA USA, Inc., is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 26-0397519.

For France: Association Law 1901 - Registration and SIREN number : 831 620 398

Under the French tax system, you will benefit from an income tax reduction of 75% of the amount of your donations up to a maximum of 1 000 euros. Beyond that amount, donations are 66% tax deductible up to an equivalent of 20% of your taxable income.